IndraLab

Statements


USP9X inhibits SMAD4. 1 / 3
| 1

reach
"USP9x shRNA delivery significantly inhibits TGF-beta-induced SMAD4 nuclear retention and eliminates PA promotion of TGF-beta-induced SMAD4 nuclear retention."